Cart 0
Compare 0 Wishlist 0
You watched 3
My Account
Menu

<h1>Speciality Medicines</h1>

Anemol Infusion
0
In stock
Model: MRM_102020
₹303
Neomol 170mg Suppository
0
In stock
Model: MRM_102817
₹57
Paraprime Injection
0
In stock
Model: MRM_102968
₹189
MOL Plus Injection
0
In stock
Model: MRM_201610
₹452
MOL IV 1000mg Injection
0
In stock
Model: MRM_201609
₹237
Dolo 1000mg Infusion
0
In stock
Model: MRM_100524
₹249
Neomol 80mg Injection
0
In stock
Model: MRM_102820
₹41
Varmol Infusion 100ml
0
In stock
Model: MRM_201154
₹303
Malidens 1000mg Injection
0
In stock
Model: MRM_102666
₹228
Neomol 250mg Suppository
0
In stock
Model: MRM_102818
₹134
Pazitop 1000mg Infusion
0
In stock
Model: MRM_201141
₹266
Prolop Infusion 100ml
0
In stock
Model: MRM_200616
₹162
Molshil 60mg Oral Disintegrating Strips
0
In stock
Model: MRM_201217
₹99
Neomol Injection
0
In stock
Model: MRM_102821
₹548
Parahenz Injection
0
In stock
Model: MRM_102967
₹396
Calpol Paediatric Drops
0
In stock
Model: MRM_92392
₹39
Neomol 300mg Injection
0
In stock
Model: MRM_102819
₹9
Calpol 120mg Suspension
0
In stock
Model: MRM_92389
₹51
Molshil 120mg Oral Disintegrating Strips
0
In stock
Model: MRM_201216
₹165
Speciality Medicines are pharmaceutical products designed to treat complex health conditions that require precise medical intervention. They are formulated to meet the specific needs of patients with chronic illnesses, rare diseases, or those needing highly targeted therapies. These medicines often undergo rigorous clinical trials to ensure their efficacy and safety.

Understanding Speciality Medicines

  • Require precise medical intervention
  • Formulated to meet specific patient needs
  • Undergo rigorous clinical trials

Key Features

  • Targeted treatment for complex health conditions
  • High level of efficacy and safety
  • Often used for chronic illnesses and rare diseases

Benefits

  • Improved patient outcomes
  • Enhanced quality of life for patients
  • Tailored approach to treatment

Challenges

  • Higher cost compared to generic medications
  • Limited availability in some regions
  • Complex regulatory processes for approval